OSTEOPOROSIS AND KLINEFELTERS-SYNDROME

被引:91
作者
HOROWITZ, M [1 ]
WISHART, JM [1 ]
OLOUGHLIN, PD [1 ]
MORRIS, HA [1 ]
NEED, AG [1 ]
NORDIN, BEC [1 ]
机构
[1] INST MED & VET SCI,DIV CLIN CHEM,ADELAIDE,SA 5000,AUSTRALIA
关键词
D O I
10.1111/j.1365-2265.1992.tb02910.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE We wanted to measure forearm mineral density and bone-related biochemical variables in patients with Klinefelter's syndrome. DESIGN Measurements made in patients with Klinefelter's syndrome were compared to those obtained in age-matched normal male volunteers. PATIENTS We studied 22 patients with Klinefelter's syndrome (12 of whom had received sex hormone therapy) and 22 control subjects. MEASUREMENTS We measured forearm mineral density, forearm fat content, fat-corrected forearm mineral density, plasma calcium and ionized calcium, serum osteocalcin, testosterone and dehydroepiandrosterone sulphate, and urinary hydroxyproline/creatinine ratio. RESULTS Forearm mineral density was lower in the Klinefelter's group than in the control subjects (P < 0.05) and below the control range in 5 patients. The fat content of the forearm was greater in the Klinefelter's group (P < 0.002). Serum osteocalcin and testosterone were lower, while ionized calcium and the urinary hydroxyproline/creatinine ratio were higher in the Klinefelter's group (P < 0.002). Serum dehydroepiandrosterone sulphate and testosterone were significantly related in the Klinefelter's group (r = 0.64, P < 0.001), but not in the controls (r = 0.22, NS). Forearm mineral density and far-corrected forearm mineral density were significantly related to serum testosterone in the Klinefelter's group (r < 0.63; P < 0.01), but not in the control subjects (r < 0.03, NS). CONCLUSIONS Decreased bone density occurs in about 25% of patients with Klinefelter's syndrome and probably reflects both decreased bone formation and increased bone resorption.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 28 条
  • [11] GREENSPAN SL, 1986, ANN INTERN MED, V104, P772
  • [12] CHANGES IN SOFT-TISSUE BODY-COMPOSITION AND PLASMA-LIPID METABOLISM DURING NANDROLONE DECANOATE THERAPY IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    HASSAGER, C
    PODENPHANT, J
    RIIS, BJ
    JOHANSEN, JS
    JENSEN, J
    CHRISTIANSEN, C
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (03): : 238 - 242
  • [13] OSTEOPOROSIS MADE EASY
    HEANEY, RP
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1990, 38 (10) : 1159 - 1160
  • [14] BONE HISTOMORPHOMETRY IN HYPOGONADAL AND EUGONADAL MEN WITH SPINAL OSTEOPOROSIS
    JACKSON, JA
    KLEEREKOPER, M
    PARFITT, AM
    RAO, DS
    VILLANEUVA, AR
    FRAME, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (01) : 53 - 58
  • [15] Syndrome characterized by gynecomastisa, aspermatogenesis without a-leydigism, and increased excietion of follicle-stimulating hormone
    Klinefelter, HF
    Reifenstein, EC
    Albright, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY, 1942, 2 (11) : 615 - 627
  • [16] Need A G, 1990, Osteoporos Int, V1, P3, DOI 10.1007/BF01880409
  • [17] CROSSOVER STUDY OF FAT-CORRECTED FOREARM MINERAL-CONTENT DURING NANDROLONE DECANOATE THERAPY FOR OSTEOPOROSIS
    NEED, AG
    HOROWITZ, M
    WALKER, CJ
    CHATTERTON, BE
    CHAPMAN, IC
    NORDIN, BEC
    [J]. BONE, 1989, 10 (01) : 3 - 6
  • [18] THE RELATION BETWEEN FOREARM AND VERTEBRAL MINERAL DENSITY AND FRACTURES IN POSTMENOPAUSAL WOMEN
    NORDIN, BEC
    WISHART, JM
    HOROWITZ, M
    NEED, AG
    BRIDGES, A
    BELLON, M
    [J]. BONE AND MINERAL, 1988, 5 (01): : 21 - 33
  • [19] THE RELATION BETWEEN CALCIUM-ABSORPTION, SERUM DEHYDROEPIANDROSTERONE, AND VERTEBRAL MINERAL DENSITY IN POSTMENOPAUSAL WOMEN
    NORDIN, BEC
    ROBERTSON, A
    SEAMARK, RF
    BRIDGES, A
    PHILCOX, JC
    NEED, AG
    HOROWITZ, M
    MORRIS, HA
    DEAM, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) : 651 - 657
  • [20] NORDIN BEC, 1989, CLIN CHEM, V35, P14